ECOLAB INC. - Annual Report 2008 | FinancialReports.eu

10-K 1 a09-1718_110k.htm 10-K

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

*Washington, D.C. 20549*

*FORM 10-K*

*(Mark One)*

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Fiscal Year Ended December 31, 2008 Commission File No. 1-9328

*OR*

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

*For the transition period from to*

*ECOLAB INC.*

(Exact name of registrant as specified in its charter)

Delaware	41-0231510
(State or other
jurisdiction of incorporation or organization)	(I.R.S. Employer
Identification No.)
370
Wabasha Street North, St. Paul, Minnesota	55102
(Address of
principal executive offices)	(Zip Code)

Registrants telephone number, including area code: 1-800-232-6522

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Name of each exchange on which registered
Common Stock, $1.00 par
value	New York Stock
Exchange, Inc.
Preferred Stock
Purchase Rights	New York Stock
Exchange, Inc.

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

x YES o NO

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

o YES x NO

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

x YES o NO

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrants knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.

Large accelerated filer x Accelerated filer o Non-accelerated filer o (Do not check if a smaller reporting company) Smaller reporting company o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

o YES x NO

Aggregate market value of voting and non-voting common equity held by non-affiliates of registrant on June 30, 2008: $10,606,696,000 (see Item 12, under Part III hereof), based on a closing price of registrants Common Stock of $42.99 per share.

The number of shares of registrants Common Stock, par value $1.00 per share, outstanding as of January 30, 2009: 236,192,852 shares.

DOCUMENTS INCORPORATED BY REFERENCE

| 1. | Portions
of the registrants Annual Report to Stockholders for the year ended
December 31, 2008 (hereinafter referred to as Annual Report) are
incorporated by reference into Parts I and II. |
| --- | --- |
| 2. | Portions
of the registrants Proxy Statement for the Annual Meeting of Stockholders to
be held May 8, 2009 and to be filed within 120 days after the
registrants fiscal year ended December 31, 2008 (hereinafter referred
to as Proxy Statement) are incorporated by reference into Part III. |

SEQ.=1,FOLIO='',FILE='C:\JMS\105542\09-1718-1\task3384587\1718-1-ba.htm',USER='105542',CD='Feb 25 20:27 2009'

Table of Contents

*TABLE OF CONTENTS*

PART I
Forward-Looking
Statements
Item
1(a)	General Development of
Business
Item
1(b)	Financial Information About
Operating Segments
Item
1(c)	Narrative Description of
Business
Item 1(d)	Financial
Information About Geographic Areas
Item 1(e)	Available
Information
Executive
Officers of the Registrant
Item
1A.	Risk Factors
Item 1B.	Unresolved Staff
Comments
Item
2.	Properties
Item 3.	Legal Proceedings
Item 4.	Submission of
Matters to a Vote of Security Holders
PART II
Item 5.	Market for
Registrants Common Equity, Related Stockholder Matters and Issuer purchases
of Equity Securities
Item 6.	Selected Financial
Data
Item 7.	Managements
Discussion and Analysis of Financial Condition and Results of Operation
Item 7A.	Quantitative
and Qualitative Disclosures about Market Risk
Item 8.	Financial
Statements and Supplementary Data
Item 9.	Changes in and
Disagreements with Accountants on Accounting and Financial Disclosure
Item 9A.	Controls and
Procedures
PART III
Item 10.	Directors,
Executive Officers of the Registrant and Corporate Governance
Item 11.	Executive
Compensation
Item 12.	Security
Ownership of Certain Beneficial Owners and Management and Related Stockholder
Matters
Item 13.	Certain
Relationships and Related Transactions and Director Independence
Item 14.	Principal
Accountant Fees and Services
PART IV
Item 15.	Exhibits and
Financial Statement Schedules
SIGNATURES
CONSENT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
EXHIBIT
INDEX

SEQ.=1,FOLIO='',FILE='C:\JMS\105542\09-1718-1\task3384587\1718-1-ba.htm',USER='105542',CD='Feb 25 20:27 2009'

Table of Contents

PART I

Except where the context otherwise requires, references in this Form 10-K to either Ecolab, Company, we and our are to Ecolab Inc. and its subsidiaries, collectively.

*Forward-Looking Statements*

This Annual Report on Form 10-K, including Managements Discussion and Analysis of Financial Condition and Results of Operation incorporated by reference into Item 7 of this Form 10-K, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include expectations concerning items such as revenue and earnings growth, raw material and delivered product costs, currency translation, business acquisitions, system implementations, restructuring charges and cost savings, cash flows, loss of customers and bad debt, debt repayments, disputes and claims, environmental and regulatory considerations, share repurchases, global economic conditions and credit risk, pension expenses and potential contributions, new accounting pronouncements, income taxes, including unrecognized tax benefits or uncertain tax positions, borrowing capacity, and liquidity requirements. Without limiting the foregoing, words or phrases such as will likely result, are expected to, will continue, is anticipated, we believe, we expect, estimate, project (including the negative or variations thereof) or similar terminology, generally identify forward-looking statements. Forward-looking statements may also represent challenging goals for us. We caution that undue reliance should not be placed on such forward-looking statements, which speak only as of the date made. Some of the factors which could cause results to differ from those expressed in any forward-looking statement are set forth under Item 1A of this Form 10-K, entitled Risk Factors.

*Item 1. Business* .

*Item 1(a) General Development of Business* .

Ecolab was incorporated as a Delaware corporation in 1924. Our fiscal year is the calendar year ending December 31.

During 2008, we continued to invest in our business to build for the future.

In December 2007, subsequent to our year-end for international operations, we purchased the Irish dairy hygiene business of Novartis Animal Health Ireland Ltd. The business, which has annual sales of approximately $3 million, became part of our International operations during the first quarter of 2008.

In February 2008, we acquired Ecovation, Inc., a Rochester, N.Y. area-based provider of renewable energy solutions and effluent management systems primarily for the food and beverage manufacturing industry in the U.S., including dairy, beverage and meat and poultry producers. 2007 sales were approximately $50 million. Ecovation became part of our U.S. Cleaning & Sanitizing operations during the first quarter of 2008.

Following the Ecovation acquisition, we combined our Water Care Services and Ecovation businesses into our Food & Beverage division.

We continued to make investments in Europe, including the establishment of our European headquarters in Zurich, Switzerland.

In November 2008, our then largest shareholder, Henkel AG & Co. KGaA (Henkel), completed the sale of all of the 72.7 million Ecolab shares it held. We repurchased 11.3 million shares directly from Henkel for $300 million, reducing our shares outstanding by approximately 4%.

*Item 1(b) Financial Information About Operating Segments* .

The financial information about reportable segments appearing under the heading Operating Segments in Note 16, located on pages 49 and 50 of the Annual Report, is incorporated herein by reference.

SEQ.=1,FOLIO='2',FILE='C:\JMS\105542\09-1718-1\task3384587\1718-1-ba.htm',USER='105542',CD='Feb 25 20:27 2009'

Table of Contents

*Item 1(c) Narrative Description of Business* .

**General** : Ecolab develops and markets premium products and services for the hospitality, foodservice, health care and industrial markets. We provide cleaning and sanitizing products and programs, as well as pest elimination, maintenance and repair services primarily to hotels and restaurants, healthcare and educational facilities, quick service (fast-food and convenience store) units, grocery stores, commercial and institutional laundries, light industry, dairy plants and farms, food and beverage processors and the vehicle wash industry. A strong commitment to customer support and sustainable solutions is a distinguishing characteristic of our business. Additional information on our business philosophy is found below under the heading Additional Information Competition of this Item 1(c).

The following description of our business is based upon our three reportable segments as reported in our consolidated financial statements. However, we pursue a Circle the Customer Circle the Globe strategy by providing products, systems and services which serve our customer base, and do so on a global basis to meet the needs of our customers various operations around the world. Therefore, one customer may utilize the products or services of all three of the segments and there is interdependence among the operating segments.

*United States Cleaning & Sanitizing Segment*

The United States Cleaning & Sanitizing segment is comprised of six business units which provide cleaning and sanitizing products and programs to United States markets.

**Institutional**** : The Institutional Division is our largest division and sells specialized cleaners and sanitizers for washing dishes, glassware, flatware, foodservice utensils and kitchen equipment (warewashing), for on-premise laundries (typically used by hotel and healthcare customers) and for general housekeeping functions, as well as food safety products and equipment, dishwasher racks and related kitchen sundries to the foodservice, lodging, educational and healthcare industries, and water filters to the foodservice industry. The Institutional Division also provides pool and spa treatment programs for hospitality and other commercial customers, as well as a broad range of janitorial cleaning and floor care products and programs to customers in hospitality, health care and commercial facilities. The Institutional Division manufactures and markets various chemical dispensing device systems, which are made available to customers, to dispense our cleaners and sanitizers. In addition, the Institutional Division markets a lease program comprised of energy-efficient dishwashing machines, detergents, rinse additives and sanitizers, including full machine maintenance.

We believe that we are the leading supplier of chemical warewashing products and programs to institutions in the United States.

The Institutional Division sells its products and programs primarily through company-employed field sales personnel. However, to a significant degree, we also utilize independent, third-party foodservice distributors to market and sell our products to smaller accounts or accounts which purchase through distributors. We provide the same customer support to accounts supplied by food distributors as to direct customers.

**Food & Beverage**** : Our Food & Beverage Division addresses cleaning and sanitation at the beginning of the food chain to facilitate the processing of products for human consumption. The Division provides detergents, cleaners, sanitizers, lubricants and animal health products, as well as cleaning systems, electronic dispensers and chemical injectors for the application of chemical products, primarily to dairy plants, dairy farms, breweries, soft-drink bottling plants, and meat, poultry and other food processors. The Food & Beverage Division is also a leading developer and marketer of antimicrobial products used in direct contact with meat, poultry, seafood and produce during processing in order to reduce microbial contamination. The Food & Beverage Division also designs, engineers and installs CIP (clean-in-place) process control systems and facility cleaning systems for its customer base. Farm products are sold through dealers and independent, third-party distributors, while plant products are sold primarily by our field sales personnel. The Food & Beverage Division also offers water care programs primarily to treat water used for heating and cooling systems and manufacturing processes. In addition, through its Ecovation business, the Food & Beverage Division offers customized wastewater treatment solutions that also can generate energy.

SEQ.=1,FOLIO='3',FILE='C:\JMS\105542\09-1718-1\task3384587\1718-1-ba.htm',USER='105542',CD='Feb 25 20:27 2009'

Table of Contents

We believe that we are one of the leading suppliers of cleaning and sanitizing products to the dairy plant, dairy farm, food, meat and poultry, and beverage/brewery processor industries in the United States.

**Kay**** : Our Kay Division (which consists of certain wholly-owned subsidiaries of Ecolab Inc.) supplies chemical cleaning and sanitizing products primarily to national and regional quick service restaurant chains. Kays products include specialty and general purpose hard surface cleaners, degreasers, sanitizers, polishes, hand care products and assorted cleaning tools. Products are sold under the Kay brand or the customers private label. In addition, Kay supports its product sales with employee training programs and technical support designed to meet the special needs of its customers. Kays customized cleaning and sanitation programs are designed to reduce labor costs and product usage while increasing sanitation levels, cleaning performance, equipment life and safety levels.

Kay employs a direct field sales force which primarily calls upon national and regional quick service restaurants and franchisees, although the sales are made to distributors who supply the chain or franchisees units.

We believe that our Kay Division is the leading supplier of chemical cleaning and sanitizing products to the traditional quick service restaurant industry in the United States. While Kays customer base has been growing, Kays business is largely dependent upon a limited number of major quick service restaurant chains and franchisees.

In addition, through Kays Food Retail business, the Division supplies cleaning and sanitizing products to the food retail (i.e., grocery store) industry. Food Retail products are sold primarily through distributors and include specialty and general purpose hard surface cleaners, degreasers, sanitizers, polishes, hand care products, assorted cleaning tools and floor care products. We provide the same customer support to accounts supplied by distributors as to direct customers.

**Healthcare**** : Our Healthcare Division provides infection prevention and other healthcare related offerings to acute care hospitals, surgery centers, dental offices and veterinary clinics. The Healthcare Divisions proprietary infection prevention products (hand hygiene, hard surface disinfectants, instrument cleaners, patient drapes, fluid control and equipment drapes) are sold primarily under the Ecolab and Microtek brand names to various departments within the acute care environment (Infection Control, Environmental Services, Central Sterile and Operating Room). Microtek Medical, acquired in November 2007, is a leader in niche branded specialty surgical drapes and fluid control products. The Healthcare Division sells its products and programs primarily through company-employed field sales personnel but also sells through healthcare distributors.

**Textile Care**** : Our Textile Care Division provides chemical laundry products and proprietary dispensing systems, as well as related programs, to large industrial and commercial laundries. Typically these customers include free-standing laundry plants used by institutions such as hotels, restaurants and healthcare facilities as well as industrial and textile rental laundries. Products and programs include laundry cleaning and specialty products, related dispensing equipment, plus water and energy management which are marketed primarily through company-employed field sales personnel and, to a lesser extent, through independent, third-party distributors. The Textile Care Divisions programs are designed to meet our customers need for exceptional cleaning, while extending the useful life of linen and reducing the customers overall operating cost.

**Vehicle Care** : Our Vehicle Care Division provides vehicle appearance products which include soaps, polishes, sealants, wheel and tire treatments and air fresheners. Products are sold to vehicle rental, fleet and consumer car wash and detail operations. Brand names utilized by the Vehicle Care Division include Blue Coral Ò , Black Magic Ò and Rain-X Ò .

*United States Other Services Segment*

The United States Other Services segment is comprised of two business units: Pest Elimination and GCS Service. In general, these businesses provide service or equipment which can augment or extend our product offering to our business customers as a part of our Circle the Customer approach.

SEQ.=1,FOLIO='4',FILE='C:\JMS\105542\09-1718-1\task3384587\1718-1-ba.htm',USER='105542',CD='Feb 25 20:27 2009'

Table of Contents

**Pest Elimination**** : Our Pest Elimination Division provides services designed to detect, eliminate and prevent pests in restaurants, food and beverage processors, educational and healthcare facilities, hotels, quick service restaurant and grocery operations and other institutional and commercial customers. These services are sold and performed by company-employed field sales and service personnel. In addition, through our EcoSure Food Safety Management business, we provide customized on-site evaluations, training and quality assurance services to foodservice operations.

**GCS Service**** : GCS Service provides equipment repair and maintenance services for the commercial food service industry. Repair services are offered for in-warranty repair, acting as the Manufacturers Authorized Service Agent, as well as after warranty repair. In addition, GCS Service operates as a parts distributor to repair service companies and end users.

*International Segment*

We conduct business in approximately 70 countries outside of the United States through wholly-owned subsidiaries or, in the case of Israel and Venezuela, through joint ventures with local partners. In other countries, selected products are sold by our export operations to distributors, agents or licensees, although the volume of those sales is not significant in terms of our overall revenues. Our largest International operations are located in Europe, Asia Pacific, Latin America and Canada, with smaller operations in Africa and the Middle East.

In general, the businesses conducted internationally are similar to those conducted in the United States but are managed on a geographic basis. The businesses which are similar to the United States Institutional and Food & Beverage businesses are the largest businesses in our International operations. They are conducted in virtually all our International locations and, compared to the United States, constitute a larger portion of the overall business. Healthcare and Textile Care are also significant businesses in our International operations, particularly in Europe. Kay also has sales in a number of International locations. A significant portion of Kays international sales are to international units of United States-based quick service restaurant chains. Consequently, a substantial portion of Kays international sales are made either to domestic or internationally-located third-party distributors who serve these chains.

Our Pest Elimination business continues to expand its geographic coverage. Since 2001, we have entered markets in Asia, Western Europe, Latin America and South Africa, with the largest operations in France and the United Kingdom.

Our other businesses are conducted less extensively in our International locations. However, in general, most of the principal businesses conducted in the United States are also operated in Canada.

International businesses are subject to the usual risks of foreign operations, including possible changes in trade and foreign investment laws, tax laws, currency exchange rates and economic and political conditions abroad. The profitability of our International operations has historically been lower than the profitability of our businesses in the United States. This has been due to the smaller scale of the International operations as well as the additional cost of operating in numerous and diverse foreign jurisdictions.

*Additional Information*

**Competition**** : Our business units have two significant classes of competitors. First, each business unit competes with a small number of large companies selling directly or through distributors on a national or international scale. Second, all of our business units have numerous smaller regional or local competitors which focus on more limited geographies, product lines and/or end-user segments.

Our objective is to achieve a significant presence in each of our business markets. In general, competition is based on customer support, product performance and price. We believe we compete principally by providing superior value, premium customer support and differentiated products to help our customers protect their brand reputation. Value is provided by state-of-the-art cleaning, sanitation and maintenance products and systems coupled with high customer support standards and continuing

SEQ.=1,FOLIO='5',FILE='C:\JMS\105542\09-1718-1\task3384587\1718-1-ba.htm',USER='105542',CD='Feb 25 20:27 2009'

Table of Contents

dedication to customer satisfaction. This is made possible, in part, by our significant on-going investment in training and technology and by our standard practice of advising customers on ways to lower operating costs and helping them comply with safety, environmental and sanitation regulations. In addition to our consultative approach, we emphasize our ability to uniformly provide a variety of related premium cleaning and sanitation programs to our customers and to provide that level of customer support to multiple locations of chain customer organizations worldwide. This approach is succinctly stated in our Circle the Customer - Circle the Globe strategy which is discussed above in this Item 1(c) under the heading General.

**Sales**** : Products, systems and services are primarily marketed in domestic and international markets by company-trained field sales personnel who also advise and assist our customers in the proper and efficient use of the products and systems in order to meet a full range of cleaning and sanitation needs. Independent, third-party distributors are utilized in several markets, as described in the business unit descriptions found under the discussion of the three reportable segments above.

**Number of Employees**** : We had approximately 26,500 employees as of December 31, 2008.

**Customers and Classes of Products**** : We believe that our business is not materially dependent upon a single customer although, as described above in this Item 1(c) under the description of the Kay business, Kay is largely dependent upon a limited number of national and international quick service chains and franchisees. Additionally, although we have a diverse customer base and no customer or distributor constitutes 10 percent or more of our consolidated revenues, we do have customers and independent, third-party distributors, the loss of which could have a material negative effect on results of operations for the affected earnings periods; however, we consider it unlikely that such an event would have a material adverse impact on our financial position. No material part of our business is subject to renegotiation or termination at the election of a governmental unit. We sell two classes of products which each constitute 10 percent or more of our sales. Sales of warewashing products in 2008, 2007 and 2006 approximated 21, 22 and 21 percent, respectively, of our consolidated net sales. In addition, through our Institutional and Textile Care businesses, we sell laundry products and provide customer support to a broad range of laundry customers. Sales of laundry products and services in 2008, 2007 and 2006 approximated 11, 10 and 10 percent, respectively, of our consolidated net sales.

**Patents and Trademarks**** : We own and license a number of patents, trademarks and other intellectual property, including through a license agreement with Henkel AG & Co. KGaA. While we have an active program to protect our intellectual property by filing for patents or trademarks, and pursuing legal action, when appropriate, to prevent infringement, we do not believe that our overall business is materially dependent on any individual patent or trademark.

**Seasonality**** : Overall our business does not have a significant degree of seasonality. However, we do experience variability in our quarterly operating results due to sales volume and business mix fluctuations in our operating segments. Note 17, entitled Quarterly Financial Data located on page 51 of the Annual Report, is incorporated herein by reference.

**Working Capital**** : We have invested in the past, and will continue to invest in the future, in merchandising equipment consisting primarily of systems used by customers to dispense our cleaning and sanitizing products. Otherwise, we have no unusual working capital requirements.

**Manufacturing and Distribution**** : We manufacture most of our products and related equipment in Company-owned manufacturing facilities. Some products are also produced for us by third-party contract manufacturers. Other products and equipment are purchased from third-party suppliers. Additional information on product/equipment sourcing is found in the segment discussions above and additional information on our manufacturing facilities is located beginning at page 15 of this Form 10-K under the heading Properties.

Deliveries to customers are made from our manufacturing plants and a network of distribution centers and public warehouses. We use common carriers, our own delivery vehicles, and distributors. Additional information on our plant and distribution facilities is located beginning at page 15 of this Form 10-K under the heading Properties.

SEQ.=1,FOLIO='6',FILE='C:\JMS\105542\09-1718-1\task3384587\1718-1-ba.htm',USER='105542',CD='Feb 25 20:27 2009'

Table of Contents

**Raw Materials**** : Raw materials purchased for use in manufacturing our products are inorganic chemicals, including alkalis, acids, phosphates, silicates and salts, and organic chemicals, including surfactants and solvents. These materials are generally purchased on an annual contract basis from a diverse group of chemical manufacturers. When practical, global sourcing is used so that purchasing or production locations can be shifted to control product costs at globally competitive levels. Pesticides used by our Pest Elimination Division are purchased as finished products under contract or purchase order from the producers or their distributors. We also purchase packaging materials for our manufactured products and components for our specialized cleaning equipment and systems. Most raw materials, or substitutes for those materials, used by us, with the exception of a few specialized chemicals which we manufacture, are available from several suppliers.

**Research and Development**** : Our research and development program consists principally of devising and testing new products, processes, techniques and equipment, improving the efficiency of existing ones, improving service program content, and evaluating the environmental compatibility of products. Key disciplines include analytical and formulation chemistry, microbiology, process and packaging engineering and product dispensing technology. Substantially all of our principal products have been developed by our research, development and engineering personnel. At times, technology has also been licensed from third parties to develop offerings. Note 13, entitled Research Expenditures located on page 44 of the Annual Report, is incorporated herein by reference.

**Environmental and Regulatory Considerations**** : Our businesses are subject to various legislative enactments and regulations relating to the protection of the environment and public health. While we cooperate with governmental authorities and take commercially practicable measures to meet regulatory requirements and avoid or limit environmental effects, some risks are inherent in our businesses. Among the risks are costs associated with transporting and managing hazardous substances, waste disposal and plant site clean-up, fines and penalties if we are found to be in violation of law, as well as modifications, disruptions or discontinuation of certain operations or types of operations including product recalls and reformulations. Additionally, although we are not currently aware of any such circumstances, there can be no assurance that future legislation or enforcement policies will not have a material adverse effect on our consolidated results of operations, financial position or cash flows. Environmental and regulatory matters most significant to us are discussed below.

*Ingredient Legislation* : Various laws and regulations have been enacted by state, local and foreign jurisdictions pertaining to the sale of products which contain phosphorous, volatile organic compounds, or other ingredients that may impact human health or the environment. Under California Proposition 65, label disclosures are required for certain products containing chemicals listed by California. Green chemistry initiatives that promote pollution prevention through research and development of safer chemicals and safer chemical processes are being advanced by certain states, including California, Maine, Massachusetts and Vermont. In 2009, green chemistry and ingredient disclosure legislation may be introduced at the federal level. To date, we generally have been able to comply with such legislative requirements by reformulation or labeling modifications. Such legislation has not had a material negative effect on our consolidated results of operations, financial position or cash flows to date.

Re-authorization of the Toxic Substances Control Act (TSCA) and a re-set of the TSCA Inventory are being discussed in the U.S. Congress. Ecolab anticipates that compliance with new requirements could be similar to the costs associated with the Registration, Evaluation and Authorization of Chemicals regulation recently adopted in the European Union, which is discussed below.

*REACH* : The European Union has developed a new regulatory framework for the Registration, Evaluation and Authorization of Chemicals (REACH). It established a new European Chemicals Agency in Helsinki, Finland, which is responsible for evaluating data to determine hazards and risks and to manage this program for authorizing chemicals for sale and distribution in Europe. Under REACH, all new and existing chemicals produced or imported into the European Union in quantities above one ton per year must be

SEQ.=1,FOLIO='7',FILE='C:\JMS\105542\09-1718-1\task3384587\1718-1-ba.htm',USER='105542',CD='Feb 25 20:27 2009'

Table of Contents

registered in a central database. Ecolab has met the pre-registration requirements of REACH, and is on track to meet the upcoming deadlines and requirements in 2009 and beyond. To help manage this new program, Ecolab is simplifying its product line and working with chemical suppliers to comply with registration requirements. For chemicals deemed to be of most concern, industry must gain specific authorization for particular uses which have been demonstrated to be safe. Ecolab has minimized use of these chemicals which are designated as chemicals of high concern. The impact of REACH will also be felt by our competitors. Potential costs to us are not yet fully quantifiable, but are not expected to significantly affect our consolidated results of operations, financial position or cash flows.

*GHS :* In 2003, the United Nations issued a standard on hazard communication and labeling of chemical products known as the Globally Harmonized System of Classification and Labeling of Chemicals (GHS). GHS is designed to facilitate international trade and increase safe handling and use of hazardous chemicals through a worldwide system that classifies chemicals based on their intrinsic hazards and communicates information about those hazards through standardized safety labeling and safety warnings. Individual countries and regional organizations either have begun to implement GHS or are considering what portions of it will be adopted and within what timeframe. Most countries in which we operate will adopt GHS-related legislation. The primary cost of compliance will revolve around authoring of material safety data sheets and product labeling, and we are working toward a phased-in approach to mitigate risks of GHS implementation. Potential costs to us are not yet fully quantifiable, but are not expected to have a material adverse effect on our consolidated results of operations, financial position or cash flows.

*Pesticide and Biocide Legislation* : Various international, federal and state environmental laws and regulations govern the manufacture and/or use of pesticides. We manufacture and sell certain disinfecting and sanitizing products which kill or reduce microorganisms (bacteria, viruses, fungi) on hard environmental surfaces and on certain food products. Such products constitute pesticides or antimicrobial pesticides under the current definitions of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), as amended by the Food Quality Protection Act of 1996, the principal federal statute governing the manufacture, labeling, handling and use of pesticides. We maintain approximately 330 product registrations with the U.S. Environmental Protection Agency (EPA). Registration entails the necessity to meet certain efficacy, toxicity and labeling requirements and to pay on-going registration fees. In addition, each state in which these products are sold requires registration and payment of a fee. In general, the states impose no substantive requirements different from those required by FIFRA. However, California and certain other states have adopted additional regulatory programs, and California imposes a tax on total pesticide sales in that state. While the cost of complying with rules as to pesticides has not had a material adverse effect on our consolidated results of operations, financial condition, or cash flows to date, the costs and delays in receiving necessary approvals for these products continue to increase. Total fees paid to the EPA and the states to obtain or maintain pesticide registrations, and for the California tax, were approximately $3,308,000 in 2008 and $2,800,000 in 2007.

In Europe, the Biocidal Product Directive (98/8/EC) (BPD) established a program to evaluate and authorize marketing of biocidal active substances and products. We are working with suppliers and industry groups to manage requirements associated with the BPD, and have met the first relevant deadline of the program by the timely submission of dossiers for active substances. Anticipated registration costs, which will be incurred through the BPD phase-in period ending in 2014, will be significant; however, these costs are not expected to significantly affect our consolidated results of operations or cash flows in any one reporting period, or our financial position.

In addition, our Pest Elimination Division applies restricted-use pesticides which it generally purchases from third parties. That Division must comply with certain standards pertaining to the use of such pesticides and to the licensing of employees who apply such pesticides. Such regulations are enforced primarily by the states or local jurisdictions in conformity with

SEQ.=1,FOLIO='8',FILE='C:\JMS\105542\09-1718-1\task3384587\1718-1-ba.htm',USER='105542',CD='Feb 25 20:27 2009'

Table of Contents

federal regulations. We have not experienced material difficulties in complying with these requirements.

*FDA Antimicrobial Product Requirements* : Various laws and regulations have been enacted by federal, state, local and foreign jurisdictions regulating certain products manufactured and sold by us for controlling microbial growth on humans, animals, foods and medical devices. In the United States, these requirements generally are administered by the U.S. Food and Drug Administration (FDA). However, the U.S. Department of Agriculture and EPA also may share in regulatory jurisdiction of antimicrobials applied to food. The FDA also has been expanding requirements applicable to such products, including proposing regulations in a Tentative Final Monograph for Healthcare Antiseptic Drug Products dated June 17, 1994, which may impose additional requirements associated with antimicrobial hand care products and associated costs when finalized by the FDA. To date, such requirements have not had a material adverse effect on our consolidated results of operations, financial position or cash flows.

*Other Environmental Legislation* : Our manufacturing plants are subject to federal, state, local or foreign jurisdiction laws and regulations relating to discharge of hazardous substances into the environment and to the transportation, handling and disposal of such substances. The primary federal statutes that apply to our activities in the United States are the Clean Air Act, the Clean Water Act, and the Resource Conservation and Recovery Act. We are also subject to the Superfund Amendments and Reauthorization Act of 1986, which imposes certain reporting requirements as to emissions of hazardous substances into the air, land and water. Similar legal requirements apply to Ecolabs facilities globally. We make capital investments and expenditures to comply with environmental laws and regulations, to ensure employee safety and to carry out our announced environmental sustainability principles. To date, such expenditures have not had a significant adverse effect on our consolidated results of operations, financial position or cash flows. Our capital expenditures for environmental health and safety projects worldwide were approximately $8,900,000 in 2008 and $8,100,000 in 2007. Approximately $4,200,000 has been budgeted globally for projects in 2009.

*Climate Change* : Various laws and regulations pertaining to climate change have been implemented or are being considered for implementation at the international, national, regional and state levels, particularly as they relate to the reduction of greenhouse gas (GHG) emissions. None of these laws and regulations directly applies to Ecolab at the present time; however, as a matter of corporate policy, Ecolab supports a balanced approach to reducing GHG emissions while sustaining economic growth and competitiveness. Ecolab has joined U.S. EPAs Climate Leaders program, and as part of that program we have pledged to develop a corporate-wide U.S. GHG emission inventory and work with EPA to set a GHG reduction goal.

*Environmental Remediation and Proceedings* : Along with numerous other potentially responsible parties (PRPs), we are currently involved with waste disposal site clean-up activities imposed by the federal Comprehensive Environmental Response, Compensation and Liability Act (CERCLA) or state equivalents at 17 sites in the United States. Additionally, we have similar liability at eight sites outside the United States. In general, under CERCLA, we and each other PRP that actually contributes hazardous substances to a Superfund site are jointly and severally liable for the costs associated with cleaning up the site. Customarily, the PRPs will work with the EPA to agree and implement a plan for site remediation. Pursuant to an Environmental Agreement dated December 7, 2000 with Henkel AG & Co. KGaA, Henkel agreed to indemnify us for certain environmental liabilities associated with the parties former joint venture in Europe. We have requested euro 261,046 (approximately $368,000 at December 31, 2008) from Henkel for environmental costs during 2008.

Based on an analysis of our experience with such environmental proceedings, our estimated share of all hazardous materials deposited on the sites referred to in the preceding paragraph, and our estimate of the contribution to be made by other PRPs which

SEQ.=1,FOLIO='9',FILE='C:\JMS\105542\09-1718-1\task3384587\1718-1-ba.htm',USER='105542',CD='Feb 25 20:27 2009'

Table of Contents

we believe have the financial ability to pay their shares, we have accrued our best estimate of our probable future costs relating to such known sites. Unasserted claims are not reflected in the accrual. In establishing accruals, potential insurance reimbursements are not included. The accrual is not discounted. It is not feasible to predict when the amounts accrued will be paid due to the uncertainties inherent in the environmental remediation and associated regulatory processes.

Our worldwide net expenditures for contamination remediation were approximately $614,000 in 2008 and $1,060,000 in 2007. Including the ChemLawn matter described below, our worldwide accruals at December 31, 2008 for probable future remediation expenditures totaled approximately $3,751,000. We review our exposure for contamination remediation costs periodically and our accruals are adjusted as considered appropriate. While the final resolution of these issues could result in costs below or above current accruals and, therefore, have an impact on our consolidated financial results in a future reporting period, we believe the ultimate resolution of these matters will not have a material effect on our consolidated results of operations, financial position or liquidity. In addition, we have retained responsibility for certain sites where our former ChemLawn business is a PRP. Currently there is one such location and ChemLawn is a de minimis party. Anticipated costs currently accrued for these matters were included in our loss from our discontinued ChemLawn operations in 1991. The accrual remaining reflects our best estimate of probable future costs for the one remaining site.

*Item 1(d) Financial Information About Geographic Areas* .

The financial information about geographic areas appearing under the heading Operating Segments in Note 16, located on pages 49 and 50 of the Annual Report, is incorporated herein by reference.

*Item 1(e) Available Information* .

Our Internet address is www.ecolab.com. Copies of our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to these reports, are available free of charge on our website at www.ecolab.com/investor as soon as reasonably practicable after such material is filed with, or furnished to, the Securities and Exchange Commission.

In addition, the following governance materials are available on our website at www.ecolab.com/investor/governance and the same information is available in print to any requesting persons, free of charge, by writing to the Corporate Secretary at our headquarters address, or by submitting an e-mail request to [email protected]: (i) charters of the Audit, Compensation, Finance and Governance Committees of our Board of Directors; (ii) our Boards Corporate Governance Principles; and (iii) our Code of Conduct and Code of Ethics for Senior Officers and Finance Associates.

*Executive Officers of the Registrant* .

The persons listed in the following table are our current executive officers. Officers are elected annually. There is no family relationship among any of the directors or executive officers, and no executive officer has been involved during the past five years in any legal proceedings described in applicable Securities and Exchange Commission regulations.

Name	Age	Office
Douglas M. Baker, Jr.	50	Chairman of the Board,
President and Chief Executive Officer	May 2006 Present
		President and Chief
Executive Officer	Jul. 2004
Apr. 2006
		President and Chief
Operating Officer	Jan. 2004
Jun. 2004

SEQ.=1,FOLIO='10',FILE='C:\JMS\c900266\09-1718-1\task3388800\1718-1-bc.htm',USER='c900266',CD='Feb 26 17:05 2009'

Table of Contents

Name	Age	Office	Positions Held Since Jan. 1, 2004
Lawrence T.	60	General Counsel and
Secretary	Feb. 2008 - Present
Bell
		Senior Vice President, General Counsel and Secretary	Jan. 2004
Jan. 2008
Larry
L. Berger	48	Chief
Technical Officer and Senior Vice President-Research, Development &
Engineering	Apr. 2008 Present (1)
John
J.	43	Vice
President and Corporate Controller	Apr. 2008 Present
Corkrean
		Vice
President and Treasurer	May 2006 Mar. 2008
		Professional Products Vice President Distributor Sales	Apr. 2005 Apr. 2006
		Professional Products Vice President and Controller	Jan. 2004 Mar. 2005
Steven
L.	54	Chief
Financial Officer	Feb. 2008 Present
Fritze
		Executive
Vice President and Chief
Financial Officer	Feb. 2004 Jan. 2008
		Senior
Vice President and Chief
Financial Officer	Jan. 2004 Jan. 2004
Robert K.	51	Senior Vice President
Global Supply Chain	Oct. 2005 Present
Gifford
		Vice President Supply
Chain Management	Sep. 2004
Sep. 2005 (2)
Thomas W. Handley	54	President Industrial and
Services North America Sector	Dec. 2007 - Present
		Executive Vice President
Industrial Sector	Apr. 2006
Nov. 2007
		Executive Vice President
Specialty Sector	Jan. 2004
Mar. 2006
Michael
A. Hickey	47	Senior
Vice President Global Business Development and General Manager GCS Service	Jan. 2009
- Present
		Senior
Vice President Global Business Development	Jan. 2006
Dec. 2008
		Senior
Vice President Global / Corporate Accounts	Nov. 2005
Dec. 2005
		Vice
President Global/Corporate Accounts, Institutional Division	Jan. 2004
Oct. 2005
Phillip J. Mason	58	President International
Sector	Dec. 2007 - Present

SEQ.=1,FOLIO='11',FILE='C:\JMS\c900266\09-1718-1\task3388800\1718-1-bc.htm',USER='c900266',CD='Feb 26 17:05 2009'

Table of Contents

Name	Age	Office	Positions Held Since Jan. 1, 2004
Phillip J. Mason (cont)		Executive Vice President
Asia Pacific and Latin America	Dec. 2004
Nov. 2007
		Senior Vice President
Strategic Business Development	May 2004
Nov. 2004 (3)
Michael L. Meyer	51	Senior Vice President-Human
Resources	Feb. 2008 Present
(4)
James A.	52	President Institutional
North America Sector	Dec. 2007 - Present
Miller
		Executive Vice President
Institutional Sector North America	Jan. 2004
Nov. 2007
Susan K. Nestegard	48	Executive Vice President
Global Healthcare Sector	Apr. 2008 - Present
		Senior Vice President
Research, Development and Engineering and Chief Technical Officer	Dec. 2004
Mar. 2008
		Vice President Research,
Development and Engineering and Chief Technical Officer	Jan. 2004
Nov. 2004
Robert P. Tabb	58	Vice President and Chief
Information Officer	Jan. 2004 Present
James H. White	44	President-EMEA Sector	Dec. 2007 Present
		Executive Vice President
EMEA	Apr. 2007
Nov. 2007
		Senior Vice President
Strategy and Marketing Development	May 2006
Mar. 2007
		Senior Vice President
Strategic Planning	Oct. 2005
Apr. 2006 (5)

| (1) | Prior to joining Ecolab in
2008, Dr. Berger spent 22 years with E.I. duPont de Nemours and Company,
most recently as Chief Technical Officer for DuPont Nonwovens. |
| --- | --- |
| (2) | Prior to joining Ecolab in
2004, Mr. Gifford served as Vice President, World Logistics and Program
Manager of Hewlett Packard Corporation for three years. Prior to Hewlett
Packard, Mr. Gifford was employed by Compaq and Tandem. |
| (3) | Mr. Mason re-joined Ecolab
in 2004, where he formerly served 23 years in various management and
executive positions, most recently as Vice President Asia Pacific. Prior to
re-joining Ecolab, Mr. Mason was employed by HAVI Group, LP, serving as
President, HPR Partners from 1997-2004. |
| (4) | Prior to joining Ecolab in
2008, Mr. Meyer was employed for 24 years by Abbott Laboratories, most
recently as Vice President Vascular Business Latin America and Canada.
Mr. Meyers management and executive experience includes 22 years in Human
Resources and assignments in Canada and Hong Kong. |
| (5) | Prior to joining Ecolab in
2005, Mr. White was employed by International Multifoods, and served as
President of its U.S. Consumer Products Division. Mr. Whites employment
also includes marketing experience at General Mills, and nine years at the
Pillsbury Company in a succession of management positions. |

*Item 1A. Risk Factors* .

The following are important factors which could affect our financial performance and could cause our actual results for future periods to differ materially from our anticipated results or other expectations, including those expressed in any forward-looking statements made in this Form 10-K. See the section entitled Forward-Looking Statements located on page 2 of this Form 10-K.

SEQ.=1,FOLIO='12',FILE='C:\JMS\c900266\09-1718-1\task3388800\1718-1-bc.htm',USER='c900266',CD='Feb 26 17:05 2009'

Table of Contents

We may also refer to this disclosure to identify factors that may cause results to differ from those expressed in other forward-looking statements made in oral presentations, including telephone conferences and/or webcasts open to the public.

Except as may be required under applicable law, we undertake no duty to update our Forward-Looking Statements.

*Our results depend upon the continued vitality of the markets we serve:* Economic downturns, and in particular downturns in the foodservice, hospitality, travel, health care and food processing industries, can adversely impact our end-users who are sensitive to changes in travel and dining activities. The current decline in economic activity is adversely affecting these markets. During such downturns, these end-users typically reduce their volume of purchases of cleaning and sanitizing products, which would likely in turn have an adverse impact on our business.

*Our results are impacted by general worldwide economic factors:* Economic factors such as the worldwide economy, interest rates and currency movements including, in particular, our exposure to foreign currency risk have affected our business in the past and are expected to have a material adverse impact on our business in the future. The global economy is currently experiencing considerable disruption and volatility, and the disruption has been particularly acute in the global credit markets. While currently these disruptions have not impaired our ability to access credit markets, there can be no assurance that there will not be a further deterioration in the markets in which we operate. As a result, ongoing disruption in the global economy could adversely affect our consolidated results of operations, financial position or cash flows.

*Our results can be adversely affected by fluctuations in the cost of raw materials:* The prices of raw materials used in our business can fluctuate from time to time, and have increased significantly in recent years. Changes in oil or raw material prices, unavailability of adequate and reasonably priced raw materials or substitutes for those raw materials, or the inability to obtain or renew supply agreements on favorable terms can adversely affect our consolidated results of operations, financial position or cash flows. In addition, recent volatility and disruption in economic activity and conditions could disrupt or delay the performance of our suppliers or otherwise impact our ability to obtain raw materials at favorable prices or on favorable terms, which may adversely affect our business.

*Our growth depends upon our ability to successfully compete with respect to value, product offerings and customer support:* Our competitive market is made up of numerous national, regional and local competitors. Our ability to compete depends in part upon our ability to maintain a superior technological capability and to continue to identify, develop and commercialize innovative, high value-added products for niche applications. There can be no assurance that we will be able to accomplish this or that technological developments by our competitors will not place certain of our products at a competitive disadvantage in the future. In addition, certain of the new products that we have under development will be offered in markets in which we do not currently compete, and there can be no assurance that we will be able to compete successfully in those new markets. If we fail to timely introduce new technologies, we may lose market share and our consolidated results of operations, financial position, or cash flows could be adversely affected.

*We enter into multi-year contracts with customers that can impact our results:* We enter into multi-year contracts with some of our customers which include terms affecting our pricing flexibility. There can be no assurance that these restraints will not have an adverse impact on our margins and operating income.

*Consolidation of our customers and vendors can affect our results:* Customers and vendors in the foodservice, hospitality, travel, healthcare and food processing industries have been consolidating in recent years and that trend may continue. This consolidation could have an adverse impact on our ability to retain customers and on our margins and operating income.

SEQ.=1,FOLIO='13',FILE='C:\JMS\c900266\09-1718-1\task3388800\1718-1-bc.htm',USER='c900266',CD='Feb 26 17:05 2009'

Table of Contents

*If we are unsuccessful in integrating acquisitions, our business could be adversely affected:* As part of our long-term strategy, we seek to acquire complementary businesses. There can be no assurance that we will find attractive acquisition candidates or succeed at effectively managing the integration of acquired businesses into existing businesses. If the expected synergies from such transactions do not materialize or we fail to successfully integrate new businesses into our existing businesses, our consolidated results of operations, financial position or cash flows could be adversely affected.

*If we are unsuccessful in executing on business investments, our business could be adversely affected:* We are making investments to develop business systems and optimize our business structure as part of our ongoing efforts to improve our efficiency and returns. If the projects in which we are investing are not successfully executed, our consolidated results of operations, financial position or cash flows could be adversely affected.

*Our business depends on our ability to comply with governmental regulations:* Our business is subject to numerous regulations relating to the environment and to the manufacture, storage, distribution, sale and use of our products. Compliance with these regulations, as well as changes in tax, fiscal, governmental and other regulatory policies expose us to potential financial liability and increase our operating costs. Regulation of our products and operations continues to increase with more stringent standards, causing increased costs of operations and potential for liability if a violation occurs. The potential cost to us relating to environmental and product registration laws and regulations is uncertain due to factors such as the unknown magnitude and type of possible contamination and clean-up costs, the complexity and evolving nature of laws and regulations, and the timing and expense of compliance. In addition, changes in accounting standards, including the adoption effective January 1, 2007 of FASB Interpretation No. 48 Accounting for Uncertainty in Income Taxes, an interpretation of FASB Statement No. 109, could increase the volatility of our quarterly tax rate.

*Extraordinary events may significantly impact our business:* The occurrence of (a) litigation or claims, (b) the loss or insolvency of a major customer or distributor, (c) war (including acts of terrorism or hostilities which impact our markets), (d) natural or manmade disasters, or (e) severe weather conditions or public health epidemics affecting the foodservice, hospitality and travel industries may have a significant, adverse impact on our business.

Defense of litigation, particularly certain types of actions such as antitrust, patent infringement, wage hour and class action lawsuits, can be costly and time consuming even if ultimately successful, and if not successful could have a material adverse impact on our consolidated results of operations, financial position or cash flows.

While we have a diverse customer base and no customer or distributor constitutes 10 percent or more of our consolidated revenues, we do have customers and independent, third-party distributors, the loss of which could have a material negative effect on our consolidated results of operations for the affected earnings periods; however, we consider it unlikely that such an event would have a material adverse impact on our financial position.

War (including acts of terrorism or hostilities), natural or manmade disasters or severe weather conditions or public health epidemics affecting the foodservice, hospitality and travel industries cause a downturn in the business of restaurants, motels and hotels and other of our customers, which in turn can have a material adverse impact on our consolidated results of operations, financial position, and cash flows.

*We depend on key personnel to lead our business:* Our continued success will largely depend on

SEQ.=1,FOLIO='14',FILE='C:\JMS\c900266\09-1718-1\task3388800\1718-1-bc.htm',USER='c900266',CD='Feb 26 17:05 2009'

Table of Contents

our ability to attract and retain a high caliber of talent and on the efforts and abilities of our executive officers and certain other key employees. Our operations could be adversely affected if for any reason such officers or key employees did not remain with us.

*Item 1B. Unresolved Staff Comments* .

We have no unresolved comments from the staff of the Securities and Exchange Commission.

*Item 2. Properties* .

Our manufacturing philosophy is to manufacture products wherever an economic, process or quality assurance advantage exists or where proprietary manufacturing techniques dictate internal production processes. Currently, most products that we sell are manufactured at our facilities.

Our manufacturing facilities produce chemical products or equipment for all of our businesses, although the businesses constituting the United States Other Services segment purchase the majority of their products and equipment from outside suppliers. Our chemical production process consists primarily of blending and packaging powders and liquids and casting solids. Our equipment manufacturing operations consist primarily of producing chemical product dispensers and injectors and other mechanical equipment and dishwasher racks and related sundries.

The following chart profiles our main manufacturing facilities with ongoing production activities. In general, manufacturing facilities located in the United States serve the United States Cleaning & Sanitizing segment and facilities located outside of the United States serve the International segment. However, certain United States facilities do manufacture products for export which are used by the International segment. The facilities having export involvement are marked with an asterisk (*).

ECOLAB OPERATIONS PLANT PROFILES

Location	Approximate Size (Sq. Ft.)	Types of Products	Majority Owned or Leased
UNITED STATES
Joliet, IL *	610,000	Solids, Liquids, Emulsions, Powders	Owned
South Beloit, IL *	313,000	Equipment	Owned
Garland, TX *	239,000	Solids, Liquids, Emulsions	Owned
Martinsburg, WV	228,000	Liquids, Emulsions	Owned
Hebron, OH	196,000	Liquids, Emulsions	Owned
Greensboro, NC	193,000	Solids, Liquids, Powders	Owned
San Jose, CA	175,000	Liquids, Emulsions	Owned
McDonough, GA*	141,000	Solids, Liquids, Emulsions	Owned
Eagan, MN *	133,000	Solids, Liquids, Emulsions, Powders	Owned
Huntington, IN *	127,000	Liquids	Owned
City of Industry, CA	125,000	Liquids	Owned
Elk Grove Village, IL *	115,000	Equipment	Leased
Fort Worth, TX	101,000	Equipment	Leased
Jacksonville, FL *	88,000	Medical Devices	Leased
Carrollton, TX	70,000	Liquids	Owned
Tyler, TX *	63,000	Medical Devices	Leased
Columbus, MS	49,000	Medical Devices	Owned
St. Louis, MO	37,000	Equipment	Leased

SEQ.=1,FOLIO='15',FILE='C:\JMS\c900266\09-1718-1\task3388800\1718-1-bc.htm',USER='c900266',CD='Feb 26 17:05 2009'

Table of Contents

Location	Approximate Size (Sq. Ft.)	Types of Products	Majority Owned or Leased
INTERNATIONAL
Chalons,
FRANCE	280,000	Liquids,
Powders	Owned
Nieuwegein,
NETHERLANDS	168,000	Powders	Owned
La
Romana, DOMINICAN REPUBLIC	160,000	Medical
Devices	Leased
Tessenderlo,
BELGIUM	153,000	Solids,
Liquids	Owned
Melbourne,
AUSTRALIA	145,000	Liquids,
Powders	Owned
Rozzano,
ITALY	126,000	Liquids	Owned
Mississauga,
CANADA	120,000	Liquids	Leased
Johannesburg,
SOUTH AFRICA	100,000	Liquids,
Powders	Owned
Hamilton,
NEW ZEALAND	96,000	Solids,
Liquids, Powders	Owned
Mullingar,
IRELAND	74,000	Liquids	Leased
Mosta,
MALTA	73,000	Medical
Devices	Leased
Sao
Paulo, BRAZIL	62,000	Solids,
Liquids	Leased
Shika,
JAPAN	60,000	Liquids	Owned
Santiago,
CHILE	60,000	Liquids,
Powders	Leased
Revesby,
AUSTRALIA	59,000	Liquids,
Powders	Owned
Cheadle
(Hulme), UNITED KINGDOM	53,000	Liquids	Leased
Guangzhou,
CHINA	50,000	Liquids,
Powders	Leased
Baglan, UNITED KINGDOM	50,000	Liquids	Leased
Noda,
JAPAN	49,000	Solids,
Liquids, Powders	Owned
Siegsdorf,
GERMANY	42,000	Equipment	Owned
Zutphen, NETHERLANDS	41,000	Medical Devices	Leased
Mexico City, MEXICO	40,000	Liquids, Powders	Owned
Maribor, SLOVENIA	39,000	Liquids, Powders	Owned
Pilar, ARGENTINA	30,000	Liquids, Powders	Owned
Shanghai, CHINA	27,000	Solids, Liquids,
Powders	Owned
Perth, AUSTRALIA	27,000	Liquids, Powders	Owned
Singapore, SINGAPORE	25,000	Liquids, Powders	Owned
Dar es Salaam, TANZANIA	23,000	Liquids, Powders	Leased
Seoul, SOUTH KOREA	22,000	Liquids, Powders	Owned
Acuna, MEXICO	21,000	Medical Devices	Leased
Racibor, POLAND	20,000	Liquids	Leased
Toulon, FRANCE	20,000	Medical Devices	Leased
Mandras, GREECE	18,000	Liquids	Owned
Varssesveld,
NETHERLANDS	17,000	Medical Devices	Leased
San Jose, COSTA RICA	11,000	Liquids, Powders	Owned
Bogota, COLOMBIA	11,000	Liquids	Leased
Cikarang, INDONESIA	10,000	Solids, Liquids,
Powders	Owned
Bangkok, THAILAND	10,000	Liquids, Powders	Owned
Manilla, PHILIPPINES	8,000	Liquids, Powders	Owned

SEQ.=1,FOLIO='16',FILE='C:\JMS\ajaegera\09-1718-1\task3394278\1718-1-be.htm',USER='ajaegera',CD='Feb 27 13:57 2009'

Table of Contents

We believe our manufacturing facilities are in good condition and are adequate to meet our existing production needs.

Most of our manufacturing plants also serve as distribution centers. In addition, we operate distribution centers around the world, all of which are leased, and utilize various public warehouses to facilitate the distribution of our products and services. In the United States, our sales and service associates are located in approximately 90 leased offices. Additional sales offices are located internationally.

Our corporate headquarters is comprised of three adjacent multi-storied buildings located in downtown St. Paul, Minnesota. The main 19-story building was constructed to our specifications and is leased through 2013. Thereafter, it is subject to multiple renewals at our option. The second building is leased through 2011 with additional options available. The third building is owned. The corporate headquarters includes an employee training center. In 2004, we purchased a 90 acre campus in Eagan, Minnesota to provide for future growth. The acquired facility houses our research and development and data center requirements as well as several of our administrative functions.

*Item 3. Legal Proceedings* .

Note 14, entitled Commitments and Contingencies located on pages 44 and 45 of the Annual Report, is incorporated herein by reference.

Other matters arising under laws relating to protection of the environment are discussed at Item 1(c) above, under the heading Environmental and Regulatory Considerations.

*Item 4. Submission of Matters to a Vote of Security Holders* .

No matters were submitted to a vote of our security holders during the fourth quarter of 2008.

*PART II*

*Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities* .

**Market Information**** : Our Common Stock is listed on the New York Stock Exchange under the symbol ECL. The Common Stock is also traded on an unlisted basis on certain other United States exchanges. The high and low sales prices of our Common Stock on the consolidated transaction reporting system during 2008 and 2007 were as follows:

Quarter	2008 — High	Low	2007 — High	Low
First	$ 52.35	$ 42.52	$ 45.37	$ 37.01
Second	$ 48.91	$ 42.89	$ 44.79	$ 41.12
Third	$ 52.16	$ 42.00	$ 47.59	$ 39.01
Fourth	$ 49.99	$ 29.56	$ 52.78	$ 44.82

The closing Common Stock price on January 30, 2009 was $33.96.

**Holders**** : On January 30, 2009, we had 5,169 holders of Common Stock of record.

**Dividends**** : We have paid Common Stock dividends for 72 consecutive years. Quarterly cash dividends of $0.115 per share were declared in February, May and August 2007. Cash dividends of $0.13 per share were declared in December 2007, and February, May and August 2008. A dividend of $0.14 per share was declared in December 2008.

SEQ.=1,FOLIO='17',FILE='C:\JMS\ajaegera\09-1718-1\task3394278\1718-1-be.htm',USER='ajaegera',CD='Feb 27 13:57 2009'

Table of Contents

**Issuer Purchases of Equity Securities**** :

Period	(a) Total number of shares purchased (1)	(b) Average price paid per share (2)	(c) Number of shares purchased as part of publicly announced plans or programs(3)		(d) Maximum number of shares that may yet be purchased under the plans or programs(3)
October 1-31,
2008	376,190	$ 40.5126	375,700		3,945,862
November 1-30,
2008	11,347,098	$ 26.5327	11,346,098	(4)	3,945,862
December 1-31,
2008	0	$ 0	0		3,945,862
Total	11,723,288	$ 26.9813	11,721,798		3,945,862

| (1) | Includes
1,490 shares reacquired from employees and/or directors as swaps for the cost
of stock options, or shares surrendered to satisfy minimum statutory tax
obligations under our stock incentive plans. |
| --- | --- |
| (2) | The
average price paid per share includes brokerage commissions associated with
publicly announced plan purchases plus the value of such other reacquired
shares. |
| (3)(4) | As
announced on October 26, 2006, our Board of Directors authorized the
repurchase of up to 10,000,000 shares of Common Stock, including shares to be
repurchased under Rule 10b5-1. We intend to repurchase all shares under
this authorization, for which no expiration date has been established, in
open market or privately negotiated transactions, subject to market
conditions. As announced on November 10, 2008, our Board of Directors
authorized the purchase of $300,000,000 of stock from Henkel AG &
Co. KGaA and its affiliate. The authorized repurchase was completed on
November 19, 2008, with the purchase of 11,346,098 shares. |

*Item 6. Selected Financial Data* .

The comparative data for the years ended December 31, 2008, 2007, 2006, 2005 and 2004 inclusive, which are set forth under the heading entitled Summary Operating and Financial Data located on pages 54 and 55 of the Annual Report, are incorporated herein by reference.

*Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operation* .

The material appearing under the heading entitled Financial Discussion, located on pages 21 through 30 of the Annual Report, is incorporated herein by reference.

*Item 7A. Quantitative and Qualitative Disclosures about Market Risk* .

The material appearing under the heading entitled Market Risk, located on page 30 of the Annual Report, is incorporated herein by reference.

*Item 8. Financial Statements and Supplementary Data* .

The financial statements and material which are an integral part of the financial statements listed under Item 15(a)(1) below and located on pages 31 through 55 of the Annual Report, are incorporated herein by reference.

*Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure* .

None.

SEQ.=1,FOLIO='18',FILE='C:\JMS\ajaegera\09-1718-1\task3394278\1718-1-be.htm',USER='ajaegera',CD='Feb 27 13:57 2009'

Table of Contents

*Item 9A. Controls and Procedures* .

**Disclosure Controls and Procedures** : As of December 31, 2008, we carried out an evaluation, under the supervision and with the participation of our management, including the Chairman of the Board, President and Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 as amended). Based upon that evaluation, our Chairman of the Board, President and Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures are effective.

**Internal Control Over Financial Reporting : Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Under the supervision and with the participation of our management, including our Chairman of the Board, President and Chief Executive Officer and our Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our evaluation under this framework, our management concluded that our internal control over financial reporting was effective as of December 31, 2008.

The Companys independent registered public accounting firm, PricewaterhouseCoopers LLP, has audited the effectiveness of the Companys internal control over financial reporting as of December 31, 2008. Their report, and our management reports, can be found in our Annual Report, the relevant portion of which has been filed as Exhibit (13) to this Form 10-K and is incorporated into Item 8 of this Form 10-K.

During the period October 1 - December 31, 2008, there were no changes in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

*PART III*

*Item 10. Directors, Executive Officers of the Registrant and Corporate Governance* .

Information about our directors is incorporated by reference from the discussion under the heading Proposal to Elect Directors located in the Proxy Statement. Information about compliance with Section 16(a) of the Securities Exchange Act of 1934, as amended, is incorporated by reference from the discussion under the heading Section 16(a) Beneficial Ownership Reporting Compliance located in the Proxy Statement. Information about our Audit Committee, including the members of the Committee, and our Audit Committee financial experts, is incorporated by reference from the discussion under the heading Corporate Governance, and sub-headings Board Committees and Audit Committee, located in the Proxy Statement. Information about our Code of Conduct is incorporated by reference from the discussion under the heading Corporate Governance Materials and Code of Conduct located in the Proxy Statement. Information regarding our executive officers is presented under the heading Executive Officers of the Registrant in Part I on pages 10 through 12 of this Form 10-K, and is incorporated herein by reference.

*Item 11. Executive Compensation* .

Information appearing under the headings entitled Executive Compensation and Director Compensation located in the Proxy Statement is incorporated herein by reference. However, pursuant to Instructions to Item 407(e)(5) of Securities and Exchange Commission Regulation S-K, the material appearing under the sub-heading Compensation Committee Report shall not be deemed to be filed with the Commission, other than as provided in this Item 11.

SEQ.=1,FOLIO='19',FILE='C:\JMS\ajaegera\09-1718-1\task3394278\1718-1-be.htm',USER='ajaegera',CD='Feb 27 13:57 2009'

Table of Contents

*Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters* .

Information appearing under the heading entitled Security Ownership located in the Proxy Statement is incorporated herein by reference.

A total of 541,813 shares of Common Stock held by our directors and executive officers, some of whom may be deemed to be affiliates of the Company, have been excluded from the computation of market value of our Common Stock on the cover page of this Form 10-K. This total represents that portion of the shares reported as beneficially owned by our directors and executive officers as of June 30, 2008, which are actually issued and outstanding.

**Equity Compensation Plan Information** : The following table presents, as of December 31, 2008, compensation plans (including individual compensation arrangements) under which our equity securities are authorized for issuance.

Plan Category	(a) Number of securities to be issued upon exercise of outstanding options, warrants and rights	(b) Weighted average exercise price of outstanding options, warrants and rights	(c) Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))
Equity compensation
plans approved by security holders	22,832,401(1)(2)	$ 34.51(2)	4,746,982
Equity
compensation plans not approved by security holders	-0-		-0-
Total	22,832,401(1)(2)	$ 34.51(2)	4,746,982

| (1) | Includes
137,276 Common Stock equivalents under our 2001 Non-Employee Director Stock
Option and Deferred Compensation Plan. These Common Stock equivalents
represent deferred compensation earned by non-employee directors and are
excluded from the calculation of weighted average exercise price of
outstanding options, warrants and rights in column (b) of this
table. |
| --- | --- |
| (2) | Includes
3,349 shares of our Common Stock subject to stock options with a
weighted-average exercise price of $30.09, which we assumed in connection
with our acquisition of Alcide Corporation effective July 30, 2004.
These assumed options are deemed exempt from shareholder approval under
Rule 303A.08 of the New York Stock Exchange in accordance with our
notice to the NYSE dated August 18, 2004. The respective Alcide plans
were amended to prohibit future grants. |

*Item 13. Certain Relationships and Related Transactions and Director Independence* .

Information appearing under the headings entitled Director Independence Standards and Determinations and Related Person Transactions located in the Proxy Statement is incorporated herein by reference.

*Item 14. Principal Accountant Fees and Services* .

Information appearing under the heading entitled Audit Fees located in the Proxy Statement is incorporated herein by reference.

SEQ.=1,FOLIO='20',FILE='C:\JMS\ajaegera\09-1718-1\task3394278\1718-1-be.htm',USER='ajaegera',CD='Feb 27 13:57 2009'

Table of Contents

PART IV

*Item 15. Exhibits and Financial Statement Schedules* .

| (a)(1) | The following financial
statements of the Company, included in the Annual Report, are incorporated
into Item 8 hereof. — (i) | | Consolidated
Statement of Income for the years ended December 31, 2008, 2007 and
2006, Annual Report page 31. |
| --- | --- | --- | --- |
| | (ii) | | Consolidated Balance
Sheet at December 31, 2008 and 2007,
Annual Report page 32. |
| | (iii) | | Consolidated Statement
of Cash Flows for the years ended December 31, 2008, 2007 and 2006, Annual Report page 33. |
| | (iv) | | Consolidated Statement
of Comprehensive Income and Shareholders Equity for the years ended
December 31, 2008, 2007 and 2006,
Annual Report page 34. |
| | (v) | | Notes to Consolidated
Financial Statements, Annual Report pages 35 through 52. |
| | (vi) | | Report of Independent
Registered Public Accounting Firm, Annual Report page 53. |
| (b)(2) | All financial statement
schedules are omitted because they are not applicable or, the required
information is shown in the consolidated financial statements or the
accompanying notes to the consolidated financial statements. All significant
majority-owned subsidiaries are included in the filed consolidated financial
statements. | | |
| | The following documents
are filed as exhibits to this Report. We will, upon request and payment of a
fee not exceeding the rate at which copies are available from the Securities
and Exchange Commission, furnish copies of any of the following exhibits to
stockholders. | | |
| | (3) | A. | Restated Certificate of
Incorporation of Ecolab Inc., dated as of February 27, 2006, effective
as of March 13, 2006 Incorporated by reference to Exhibit (3)A of
our Form 10-K Annual Report for the year ended December 31, 2005. |
| | | B. | By-Laws, as
amended through August 1, 2008 Incorporated by reference to
Exhibit (3.1) of our Form 8-K dated November 10, 2008. |
| | (4) | A. | Common Stock -
see Exhibits (3)A and (3)B. |
| | | B. | Form of
Common Stock Certificate effective February 28, 2007 Incorporated by
reference to Exhibit (4)B of our Form 10-K Annual Report for the
year ended December 31, 2006. |
| | | C. | Rights
Agreement, dated as of February 24, 2006, between Ecolab Inc. and
Computershare Investor Services, LLC, as Rights Agent, which includes the
following exhibits thereto: (i) Exhibit A Form of
Certificate of Designation, Preferences and Rights of Series A Junior
Participating Preferred Stock and (ii) Exhibit B Form of
Rights Certificate Incorporated by reference to Exhibit (4)C of our
Form 10-K Annual Report for the year ended December 31, 2005. |
| | | D. | Amended and
Restated Indenture, dated as of January 9, 2001, between Ecolab Inc. and
The Bank of New York Trust Company, N.A. (as successor in interest to J. P.
Morgan Trust Company, National Association and Bank One, NA) as Trustee -
Incorporated by reference to Exhibit (4)(A) of our Current Report
on Form 8-K dated January 23, 2001. |

SEQ.=1,FOLIO='21',FILE='C:\JMS\ajaegera\09-1718-1\task3394278\1718-1-be.htm',USER='ajaegera',CD='Feb 27 13:57 2009'

Table of Contents

| | F. | Officers
Certificate establishing terms and conditions of 6.875% Notes due February 1,
2011 - Incorporated by reference to Exhibit 4(B) of
our Form 8-K dated January 23, 2001. — Form of
6.875% Note due February 2,
2011 - Incorporated by reference to Exhibit 4(C) of our Form 8-K
dated January 23, 2001. | |
| --- | --- | --- | --- |
| | G. | Supplemental Indenture, dated as of February 8,
2008, between Ecolab Inc. and The Bank of New York Trust Company, N.A., as
Trustee Incorporated by reference to Exhibit 4.2 of our Current Report
on Form 8-K dated February 8, 2008. | |
| | H. | Form of
4.875% Note due February 15,
2015 Included in Exhibit (4)H above. | |
| | Copies of other constituent
instruments defining the rights of holders of our long-term debt are not
filed herewith, pursuant to Section (b)(4)(iii) of Item 601 of
Regulation S-K, because the aggregate amount of securities authorized under
each of such instruments is less than 10% of our total assets on a
consolidated basis. We will, upon
request by the Securities and Exchange Commission, furnish to the Commission
a copy of each such instrument. | | |
| (10)A. | (i) | Multicurrency Credit
Agreement, dated as of September 29, 1993, as amended and restated as of
June 1, 2006, among Ecolab Inc., the financial institutions party
thereto as Banks from time to time, the financial institutions party thereto
as Issuing Banks from time to time, Citibank, N.A., as administrative agent
for the Banks and Issuing Banks thereunder, Citibank International PLC, as
agent for the Banks in connection with certain of the Eurocurrency Advances,
and JPMorgan Chase Bank, N.A., as syndication agent Incorporated by
reference to Exhibit (10) of our Form 8-K dated June 1,
2006. | |
| | (ii) | Extension Confirmation
Notice, dated May 14, 2007, under the Multicurrency Credit Agreement,
dated as of September 29, 1993, as amended and restated as of June 1,
2006 Incorporated by reference to Exhibit (10) of our Form 8-K
dated May 14, 2007. | |
| | (iii) | Increase of Commitments
Agreement dated as of October 29, 2007 by and among Ecolab Inc.,
Citibank, N.A., JPMorgan Chase Bank, N.A., Credit Suisse, Cayman Islands
Branch, National Association, Wells Fargo Bank, National Association, ABN
AMRO Bank N.A., Bank of America, N.A. and Barclays Bank PLC, as increasing
banks, and Citibank, N.A., as agent Incorporated by reference to Exhibit (10) of
our Form 10-Q for the quarter ended September 30, 2007. | |
| B. | Documents comprising
global Commercial Paper Programs | | |
| | (i) | U.S.
$200,000,000 Euro-Commercial Paper Programme | |
| | | (a) | Amended and Restated Dealer Agreement dated 2 December 2005
between Ecolab Inc. (as Guarantor), Ecolab B.V. and Ecolab Holding GmbH (as
Issuers), Ecolab Inc., Credit Suisse First Boston (Europe) Limited (as
Arranger), and Citibank International plc and Credit Suisse First Boston
(Europe) Limited (as Dealers) Incorporated by reference to Exhibit (10)B(i)(a) of
our Form 10-K Annual Report for the year ended December 31, 2005. |
| | | (b) | Amended and Restated Note Agency Agreement dated as of 2 December 2005
between Ecolab Inc., Ecolab B.V. and Ecolab Holding GmbH (as Issuers) and
Citibank, N.A. as Issue and Paying Agent Incorporated by reference to Exhibit (10)B(i)(b) of
our Form 10-K Annual Report for the year ended December 31, 2005. |

SEQ.=1,FOLIO='22',FILE='C:\JMS\105542\09-1718-1\task3384587\1718-1-bg.htm',USER='105542',CD='Feb 25 20:30 2009'

Table of Contents

| | (ii) | (c) Deed of Covenant made on 2 December 2005
by Ecolab Inc., Ecolab B.V. and Ecolab Holding GmbH Incorporated by
reference to Exhibit (10)B(i)(c) of our Form 10-K Annual
Report for the year ended December 31, 2005. (d) Deed of Guarantee made on 2 December 2005
Incorporated by reference to Exhibit (10)B(i)(d) of our Form 10-K
Annual Report for the year ended December 31, 2005. — U.S. $600,000,000 U.S. Commercial Paper Program |
| --- | --- | --- |
| | | (a) Form of Commercial Paper Dealer
Agreement for 4 (2) Program.
Agreements have been executed with Salomon Smith Barney, Inc. and
J.P. Morgan Securities Inc., Wachovia Securities, LLC and Banc of America
Securities LLC - Incorporated by reference to Exhibit (10)A(ii)(a) of
our Form 10-Q for the quarter ended June 30, 2003. (b) Issuing and Paying Agency Agreement dated
as of July 10, 2000 between Ecolab Inc. and Bank One, National
Association as Issuing and Paying Agent - Incorporated by reference to Exhibit (10)A(ii)(b) of
our Form 10-Q for the quarter ended June 30, 2003. |
| C. | (i) | Ecolab Inc. 1997 Stock Incentive Plan, as Amended and Restated as of August 18,
2000 - Incorporated by reference to Exhibit (10) of our Form 10-Q
for the quarter ended September 30, 2000. |
| | (ii) | Non-Statutory Stock Option Agreement as in effect for grants through May 12,
2000 Incorporated by reference to Exhibit (10)B(i) of our Form 10-Q
for the quarter ended June 30, 2004. |
| | (iii) | Non-Statutory Stock Option Agreement as in effect for grants beginning May 13,
2000 through May 10, 2002 Incorporated by reference to Exhibit (10)B(ii) of
our Form 10-Q for the quarter ended June 30, 2004. |
| D. | (i) | 1995 Non-Employee Director Stock Option Plan Incorporated by
reference to Exhibit (10)D(i) of our Form 10-K Annual Report
for the year ended December 31, 2006. |
| | (ii) | Amendment No. 1
to 1995 Non-Employee Director Stock Option Plan effective February 25,
2000 - Incorporated by reference to Exhibit (10)E(ii) of our Form 10-K
Annual Report for the year ended December 31, 1999. |
| | (iii) | Amendment No. 2
to 1995 Non-Employee Director Stock Option Plan effective May 11, 2001 -
Incorporated by reference to Exhibit (10)G(iii) of our Form 10-K
Annual Report for the year ended December 31, 2002. |
| | (iv) | Amendment No. 3 to 1995 Non-Employee Director Stock Option Plan,
adopted October 31, 2008. |
| E. | (i) | Ecolab Inc. 2001
Non-Employee Director Stock Option and Deferred Compensation Plan as amended
effective May 1, 2004 Incorporated by reference to Exhibit (10)H(ii) of
our Form 10-K Annual Report for the year ended December 31, 2003. |
| | (ii) | Amendment No. 1
adopted December 15, 2004 to Ecolab Inc. 2001 Non-Employee Director
Stock Option and Deferred Compensation Plan, as amended and restated
effective May 1, 2004, with respect to the American Jobs Creation Act of
2004 Incorporated by reference to Exhibit (10)F(ii) of our Form 10-K
Annual Report for the year ended December 31, 2004. |

SEQ.=1,FOLIO='23',FILE='C:\JMS\105542\09-1718-1\task3384587\1718-1-bg.htm',USER='105542',CD='Feb 25 20:30 2009'

Table of Contents

| | (iii) | Master Agreement Relating to Options (as in effect
through May 7, 2004) Incorporated by reference to Exhibit (10)D(i) of
our Form 10-Q for the quarter ended June 30, 2004. |
| --- | --- | --- |
| | (iv) | Master Agreement Relating to Periodic Options, as
amended effective as of May 1, 2004 Incorporated by reference to Exhibit (10)D(ii) of
our Form 10-Q for the quarter ended June 30, 2004. |
| | (v) | Amendment No. 2 to Ecolab Inc. 2001
Non-Employee Director Stock Option and Deferred Compensation Plan, as amended
effective May 2, 2008 Incorporated by reference to Exhibit (10)A
of our Form 10-Q for the quarter ended September 30, 2008. |
| | (vi) | Amendment No. 1 to Master Agreement Relating to
Periodic Options, as amended effective May 2, 2008 Incorporated by
reference to Exhibit (10)B of our Form 10-Q for the quarter ended September 30,
2008. |
| | (vii) | Amendment No. 3
to Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred
Compensation Plan (as Amended and Restated Effective as of May 1, 2004). |
| F. | Note Purchase
Agreement, dated as of July 26, 2006 by and among Ecolab Inc. and the
Purchasers party thereto Incorporated by reference to Exhibit (10) of
our Form 8-K dated July 26, 2006. | |
| G. | Form of
Director Indemnification Agreement.
Substantially identical agreements are in effect as to each of our
directors Incorporated by reference to Exhibit (10)I of our Form 10-K
Annual Report for the year ended December 31, 2003. | |
| H. | (i) | Ecolab Executive Death Benefits Plan, as amended and
restated effective March 1, 1994 Incorporated by reference to Exhibit (10)H(i) of
our Form 10-K Annual Report for the year ended December 31, 2006.
See also Exhibit (10)N hereof. |
| | (ii) | Amendment No. 1 to Ecolab Executive Death
Benefits Plan Incorporated by reference to Exhibit (10)H(ii) of
our Form 10-K Annual Report for the year ended December 31, 1998. |
| | (iii) | Second Declaration of Amendment to Ecolab Executive
Death Benefits Plan, effective March 1, 1998 - Incorporated by reference
to Exhibit (10)H(iii) of our Form 10-K Annual Report for the
year ended December 31, 1998. |
| | (iv) | Amendment No. 3 to the Ecolab Executive Death
Benefits Plan, effective August 12, 2005 Incorporated by reference to Exhibit (10)B
of our Form 8-K dated December 13, 2005. |
| I. | Ecolab Executive
Long-Term Disability Plan, as amended and restated effective January 1,
1994 Incorporated by reference to Exhibit (10)I of our Form 10-K
Annual Report for the year ended December 31, 2004. See also Exhibit (10)N
hereof. | |
| J. | Ecolab Financial
Counseling Plan (Effective January 1, 2005). | |
| K. | Ecolab
Supplemental Executive Retirement Plan (Amended and Restated effective as of January 1,
2005). | |
| L. | Ecolab Mirror
Savings Plan (Amended and Restated effective as of January 1, 2005). | |
| M. | Ecolab Mirror
Pension Plan (Amended and Restated effective as of January 1, 2005). | |

SEQ.=1,FOLIO='24',FILE='C:\JMS\105542\09-1718-1\task3384587\1718-1-bg.htm',USER='105542',CD='Feb 25 20:30 2009'

Table of Contents

| N. | Ecolab Inc. Administrative Document for Non-Qualified Plans (Amended
and Restated effective as of January 1, 2005). | |
| --- | --- | --- |
| O. | (i) | Ecolab Inc. Management Performance Incentive Plan,
as amended and restated on February 28, 2004 Incorporated by reference
to Exhibit (10)A of our Form 10-Q for the quarter ended March 31,
2004. |
| | (ii) | Amendment No. 1 adopted February 26, 2005
to the Ecolab Inc. Management Performance Incentive Plan Incorporated by
reference to Exhibit (10)O(ii) of our Form 10-K Annual Report
for the year ended December 31, 2004. |
| P. | Ecolab Inc. Change in
Control Severance Compensation Policy, effective as of January 1, 2005,
adopted December 19, 2008. | |
| Q. | Description of Ecolab Management Incentive Plan. | |
| R. | Stock Purchase
Agreement, dated November 10, 2008, among Henkel AG & Co. KGaA,
Henkel Corporation and Ecolab Inc. Incorporated by reference to Exhibit (10.1)
of our Form 8-K dated November 10,
2008. | |
| S. | (i) | Ecolab Inc. 2002
Stock Incentive Plan Incorporated by reference to Exhibit (10) of
our Form 10-Q for the quarter ended June 30, 2002 |
| | (ii) | Non-Statutory
Stock Option Agreement as in effect for grants beginning May 11, 2002
through August 12, 2003 Incorporated by reference to Exhibit (10)A(i) of
our Form 10-Q for the quarter ended June 30, 2004. |
| | (iii) | Non-statutory
Stock Option Agreement as in effect for grants beginning August 13, 2003
Incorporated by reference to Exhibit (10)A(ii) of our Form 10-Q
for the quarter ended June 30, 2004. |
| T. | 2009 Named
Executive Officer Summary of Base Salary, Bonus Award Opportunities, and
Executive Benefits and Perquisites. | |
| U. | Non-Employee
Director Compensation and Benefits Summary. | |
| V. | (i) | Ecolab Inc. 2005 Stock Incentive Plan Incorporated
by reference to Exhibit (10)A of our Form 8-K dated May 6,
2005. |
| | (ii) | Amendment No. 1 to Ecolab Inc. 2005 Stock
Incentive Plan, adopted October 31, 2008. |
| | (iii) | Sample form of Non-Statutory Stock Option Agreement
under the Ecolab Inc. 2005 Stock Incentive Plan in effect for grants prior to
October 31, 2008 Incorporated by reference to Exhibit (10)B of
our Form 8-K dated May 6, 2005. |
| | (iv) | Sample form of Non-Statutory Stock Option Agreement
under the Ecolab Inc. 2005 Stock Incentive Plan in effect for grants after October 31,
2008. |
| | (v) | Sample form of Restricted Stock Award Agreement
under the Ecolab Inc. 2005 Stock Incentive Plan Incorporated by reference
to Exhibit (10)W(iii) of our Form 10-K Annual Report for the
year ended December 31, 2006. |
| W. | Policy on
Reimbursement of Incentive Payments adopted December 4, 2008. | |
| (13) | Those portions
of our Annual Report to Stockholders for the year ended December 31,
2008 which are incorporated by reference into Parts I and II hereof. | |

SEQ.=1,FOLIO='25',FILE='C:\JMS\105542\09-1718-1\task3384587\1718-1-bg.htm',USER='105542',CD='Feb 25 20:30 2009'

Table of Contents

| (14)A. | Code of Conduct
Incorporated by reference to Exhibit (99)A of our Form 10-K Annual
Report for the year ended December 31, 2003. |
| --- | --- |
| (14)B. | Code of Ethics for
Senior Officers and Finance Associates Incorporated by reference to
Exhibit (99)B of our Form 10-K Annual Report for the year ended
December 31, 2003. |
| (21) | List of Subsidiaries as
of January 31, 2009. |
| (23) | Consent of Independent
Registered Public Accounting Firm at page 29 hereof is filed as a part
hereof. |
| (24) | Powers of Attorney. |
| (31) | Rule 13a-14(a) Certifications. |
| (32) | Section 1350
Certifications. |

SEQ.=1,FOLIO='26',FILE='C:\JMS\105542\09-1718-1\task3384587\1718-1-bg.htm',USER='105542',CD='Feb 25 20:30 2009'

Table of Contents

*EXECUTIVE COMPENSATION PLANS AND ARRANGEMENTS*

Included in the preceding list of exhibits are the following management contracts or compensatory plans or arrangements:

Exhibit No.	Description
(10)C.	Ecolab Inc. 1997
Stock Incentive Plan.
(10)D.	1995
Non-Employee Director Stock Option Plan.
(10)E.	Ecolab Inc. 2001
Non-Employee Director Stock Option and Deferred Compensation Plan.
(10)G.	Form of
Director Indemnification Agreement.
(10)H.	Ecolab Executive
Death Benefits Plan.
(10)I.	Ecolab Executive
Long-Term Disability Plan.
(10)J.	Ecolab Executive
Financial Counseling Plan.
(10)K.	Ecolab Supplemental
Executive Retirement Plan.
(10)L.	Ecolab Mirror
Savings Plan.
(10)M.	Ecolab Mirror
Pension Plan.
(10)N.	Ecolab Inc.
Administrative Document for Non-Qualified Plans.
(10)O.	Ecolab Inc.
Management Performance Incentive Plan.
(10)P.	Ecolab Inc.
Change in Control Severance Compensation Policy.
(10)Q.	Description of
Ecolab Inc. Management Incentive Plan.
(10)S.	Ecolab Inc. 2002
Stock Incentive Plan.
(10)T.	2009 Named
Executive Officer Summary of Base Salary, Bonus Award Opportunities, and
Executive Benefits and Perquisites.
(10)U.	Non-Employee
Director Compensation and Benefits Summary.
(10)V.	Ecolab Inc. 2005
Stock Incentive Plan.
(10)W.	Policy on
Reimbursement of Incentive Payments adopted December 4, 2008.

SEQ.=1,FOLIO='27',FILE='C:\JMS\105542\09-1718-1\task3384587\1718-1-bg.htm',USER='105542',CD='Feb 25 20:30 2009'

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, Ecolab Inc. has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on the 27 th day of February, 2009.

ECOLAB INC.
(Registrant)
By:	/s/Douglas M. Baker, Jr.
	Douglas M. Baker, Jr.
	Chairman
of the Board, President and
Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of Ecolab Inc. and in the capacities indicated, on the 27 th day of February 2009.

| /s/Douglas
M. Baker, Jr. | Chairman
of the Board, President |
| --- | --- |
| Douglas
M. Baker, Jr. | and
Chief Executive Officer |
| | (Principal Executive Officer and Director) |
| /s/Steven L. Fritze | Chief
Financial Officer |
| Steven L. Fritze | (Principal Financial Officer) |
| /s/John J. Corkrean | Vice President and Controller |
| John J. Corkrean | (Principal Accounting Officer) |
| /s/Lawrence
T. Bell | Directors |
| Lawrence
T. Bell | |
| as
attorney-in-fact for: | |
| Barbara
J. Beck, Les S. Biller, Richard U. De Schutter, Jerry A. Grundhofer, Joel W.
Johnson, Jerry W. Levin, Robert L. Lumpkins, Beth M. Pritchard and John J.
Zillmer | |

SEQ.=1,FOLIO='28',FILE='C:\JMS\105542\09-1718-1\task3384587\1718-1-bg.htm',USER='105542',CD='Feb 25 20:30 2009'

Table of Contents

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Registration Nos. 2-90702; 33-18202; 33-55986; 33-56101; 333-95043; 333-109890; 33-34000; 33-56151; 333-18627; 333-109891; 33-39228; 33-56125; 333-70835; 33-60266; 333-95041; 333-18617; 333-79449; 333-40239; 333-95037; 333-50969; 333-58360; 333-97927; 333-115567; 333-129427; 333-129428; 333-140988; 333-115568; 333-132139; and 333-149148) and Form S-3 (Registration No. 333-149052) of Ecolab Inc. of our report dated February 27, 2009 relating to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appears in the Annual Report to Shareholders, which is incorporated in this Annual Report on Form 10-K.

| /s/
PricewaterhouseCoopers LLP |
| --- |
| PricewaterhouseCoopers
LLP |

Minneapolis, Minnesota

February 27, 2009

SEQ.=1,FOLIO='29',FILE='C:\JMS\105542\09-1718-1\task3384587\1718-1-bg.htm',USER='105542',CD='Feb 25 20:30 2009'

Table of Contents

EXHIBIT INDEX

The following documents are filed as exhibits to this Report.

Exhibit No.		Document	Method of Filing
(3)	A.	Restated
Certificate of Incorporation of Ecolab Inc., dated as of February 27,
2006, effective as of March 13, 2006.	Incorporated by
reference to Exhibit (3)A of our Form 10-K Annual Report for the
year ended December 31, 2005.
	B.	By-Laws, as
amended through August 1, 2008.	Incorporated by
reference to Exhibit (3.1) of our Form 8-K dated November 10,
2008.
(4)	A.	Common Stock.	See Exhibits
(3)A and (3)B.
	B.	Form of
Common Stock Certificate effective February 28, 2007.	Incorporated by
reference to Exhibit (4)B of our Form 10-K Annual Report for the
year ended December 31, 2006.
	C.	Rights
Agreement, dated as of February 24, 2006, between Ecolab Inc. and
Computershare Investor Services, LLC, as Rights Agent, which includes the
following exhibits thereto: (i) Exhibit A Form of
Certificate of Designation, Preferences and Rights of Series A Junior
Participating Preferred Stock and (ii) Exhibit B Form of
Rights Certificate.	Incorporated by
reference to Exhibit (4)C of our Form 10-K Annual Report for the
year ended December 31, 2005.
	D.	Amended and
Restated Indenture dated as of January 9, 2001 between Ecolab Inc. and
The Bank of New York Trust Company, N.A. (as successor to J.P. Morgan Trust
Company, National Association and Bank One, NA as Trustee.)	Incorporated by
reference to Exhibit (4)(A) of our Current Report on Form 8-K
dated January 23, 2001.
	E.	Officers
Certificate establishing terms and conditions of 6.875% Notes due
February 1, 2011.	Incorporated by
reference to Exhibit 4(B) of our Form 8-K dated
January 23, 2001.
	F.	Form of
6.875% Note due February 2, 2011.	Incorporated by
reference to Exhibit 4(C) of our Form 8-K dated
January 23, 2001.
	G.	Supplemental
Indenture, dated as of February 8, 2008, between Ecolab Inc. and The
Bank of New York Trust Company, N.A., as Trustee.	Incorporated by
reference to Exhibit 4.2 of our Current Report on Form 8-K dated
February 8, 2008.

SEQ.=1,FOLIO='30',FILE='C:\JMS\105542\09-1718-1\task3384587\1718-1-bi.htm',USER='105542',CD='Feb 25 20:31 2009'

Table of Contents

| I. — A. | (i) | Form of
4.875% Note due February 15, 2015. — Multicurrency Credit Agreement,
dated as of September 29, 1993, as amended and restated as of
June 1, 2006, among Ecolab Inc., the financial institutions party
thereto as Banks from time to time, the financial institutions party thereto
as Issuing Banks from time to time, Citibank, N.A., as administrative agent
for the Banks and Issuing Banks thereunder, Citibank International PLC, as
agent for the Banks in connection with certain of the Eurocurrency Advances,
and JPMorgan Chase Bank, N.A., as syndication agent. | | Included in
Exhibit (4)H above. — Incorporated by reference
to Exhibit (10) of our Form 8-K dated June 1, 2006. |
| --- | --- | --- | --- | --- |
| | (ii) | Extension
Confirmation Notice, dated May 14, 2007, under the Multicurrency Credit
Agreement, dated as of September 29, 1993, as amended and restated as of
June 1, 2006. | | Incorporated by
reference to Exhibit (10) of our Form 8-K dated May 14,
2007. |
| | (iii) | Increase of
Commitments Agreement dated as of October 29, 2007 by and among Ecolab
Inc., Citibank, N.A., JPMorgan Chase Bank, N.A., Credit Suisse, Cayman Islands
Branch, National Association, Wells Fargo Bank, National Association, ABN
AMRO Bank N.A., Bank of America, N.A. and Barclays Bank PLC, as increasing
banks, and Citibank, N.A., as agent. | | Incorporated by
reference to Exhibit (10) of our Form 10-Q for the quarter
ended September 30, 2007. |
| B. | | Documents
comprising global Commercial Paper Programs. | | |
| | (i) | U.S. $200,000,000 Euro-Commercial Paper Programme. | | |
| | | (a) | Amended and
Restated Dealer Agreement dated 2 December 2005 between Ecolab Inc. (as
Guarantor), Ecolab B.V. and Ecolab Holding GmbH (as Issuers), Ecolab Inc.,
Credit Suisse First Boston (Europe) Limited (as Arranger), and Citibank
International plc and Credit Suisse First Boston (Europe) Limited (as Dealers). | Incorporated by
reference to Exhibit (10)B(i)(a) of our Form 10-K Annual
Report for the year ended December 31, 2005. |
| | | (b) | Amended and
Restated Note Agency Agreement dated as of 2 December 2005 between
Ecolab Inc., Ecolab B.V. and Ecolab Holding GmbH (as Issuers) and Citibank,
N.A. as Issue and Paying Agent. | Incorporated by
reference to Exhibit (10)B(i)(b) of our Form 10-K Annual
Report for the year ended December 31, 2005. |

SEQ.=1,FOLIO='31',FILE='C:\JMS\105542\09-1718-1\task3384587\1718-1-bi.htm',USER='105542',CD='Feb 25 20:31 2009'

Table of Contents

| | | (d) | Deed of Covenant
made on 2 December 2005 by Ecolab Inc., Ecolab B.V. and Ecolab Holding
GmbH. — Deed of
Guarantee made on 2 December 2005. | | Incorporated by
reference to Exhibit (10)B(i)(c) of our Form 10-K Annual
Report for the year ended December 31, 2005. — Incorporated by
reference to Exhibit (10)B(i)(d) of our Form 10-K Annual
Report for the year ended December 31, 2005. |
| --- | --- | --- | --- | --- | --- |
| | (ii) | U.S.
$600,000,000 U.S. Commercial Paper Program. | | | |
| | | | (a) | Form of
Commercial Paper Dealer Agreement for 4 (2) Program. Agreements have
been executed with Salomon Smith Barney, Inc., Wachovia Securities, LLC
and Banc of America Securities LLC. | Incorporated by
reference to Exhibit (10)A(ii)(a) of our Form 10-Q for the
quarter ended June 30, 2003. |
| | | | (b) | Issuing and
Paying Agency Agreement dated as of July 10, 2000 between Ecolab Inc.
and Bank One, National Association as Issuing and Paying Agent. | Incorporated by
reference to Exhibit (10)A(ii)(b) of our Form 10-Q for the
quarter ended June 30, 2003. |
| C. | (i) | Ecolab Inc. 1997
Stock Incentive Plan, as Amended and Restated as of August 18, 2000. | | | Incorporated by
reference to Exhibit (10) of our Form 10-Q for the quarter
ended September 30, 2000. |
| | (ii) | Non-Statutory
Stock Option Agreement as in effect for grants through May 12, 2000. | | | Incorporated by
reference to Exhibit (10)B(i) of our Form 10-Q for the quarter
ended June 30, 2004. |
| | (iii) | Non-Statutory
Stock Option Agreement as in effect for grants beginning May 13, 2000
through May 10, 2002. | | | Incorporated by
reference to Exhibit (10)B(ii) of our Form 10-Q for the
quarter ended June 30, 2004. |
| D. | (i) | 1995
Non-Employee Director Stock Option Plan. | | | Incorporated by
reference to Exhibit (10)D(i) of our Form 10-K Annual Report
for the year ended December 31, 2006. |
| | (ii) | Amendment
No. 1 to 1995 Non-Employee Director Stock Option Plan effective
February 25, 2000. | | | Incorporated by
reference to Exhibit (10)E(ii) of our Form 10-K Annual Report
for the year ended December 31, 1999. |
| | (iii) | Amendment
No. 2 to 1995 Non-Employee Director Stock Option Plan effective
May 11, 2001. | | | Incorporated by
reference to Exhibit (10)G(iii) of our Form 10-K Annual Report
for the year ended December 31, 2002. |

SEQ.=1,FOLIO='32',FILE='C:\JMS\105542\09-1718-1\task3384587\1718-1-bi.htm',USER='105542',CD='Feb 25 20:31 2009'

Table of Contents

| | (iv) | Amendment No. 3 to
1995 Non-Employee Director Stock Option Plan, adopted October 31, 2008. | Filed herewith
electronically. |
| --- | --- | --- | --- |
| E. | (i) | Ecolab Inc. 2001
Non-Employee Director Stock Option and Deferred Compensation Plan as amended
effective May 1, 2004. | Incorporated by
reference to Exhibit (10)H(ii) of our Form 10-K Annual Report
for the year ended December 31, 2003. |
| | (ii) | Amendment
No. 1 adopted December 15, 2004 to Ecolab Inc. 2001 Non-Employee
Director Stock Option and Deferred Compensation Plan, as amended and restated
effective May 1, 2004, with respect to the American Jobs Creation Act of
2004. | Incorporated by
reference to Exhibit (10)F(ii) of our Form 10-K Annual Report
for the year ended December 31, 2004. |
| | (iii) | Master Agreement
Relating to Options (as in effect through May 7, 2004). | Incorporated by
reference to Exhibit (10)D(i) of our Form 10-Q for the quarter
ended June 30, 2004. |
| | (iv) | Master Agreement Relating
to Periodic Options, as amended effective as of May 1, 2004. | Incorporated by
reference to Exhibit (10)D(ii) of our Form 10-Q for the
quarter ended June 30, 2004. |
| | (v) | Amendment No. 2 to
Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation
Plan, as amended effective May 2, 2008. | Incorporated by
reference to Exhibit (10)A of our Form 10-Q for the quarter ended
September 30, 2008. |
| | (vi) | Amendment No. 1 to
Master Agreement Relating to Periodic Options, as amended effective
May 2, 2008. | Incorporated by
reference to Exhibit (10)B of our Form 10-Q for the quarter ended
September 30, 2008. |
| | (vii) | Amendment No. 3 to
Ecolab Inc. 2001 Non-Employee Director Stock Option and Deferred Compensation
Plan (as Amended and Restated Effective as of May 1, 2004). | Filed herewith
electronically. |
| F. | | Note Purchase
Agreement, dated as of July 26, 2006 by and among Ecolab Inc. and the
Purchasers party thereto. | Incorporated by
reference to Exhibit (10) of our Form 8-K dated July 26,
2006. |
| G. | | Form of
Director Indemnification Agreement. Substantially identical agreements are in
effect as to each of our directors. | Incorporated by
reference to Exhibit (10)I of our Form 10-K Annual Report for the
year ended December 31, 2003. |
| H. | (i) | Ecolab Executive Death
Benefits Plan, as amended and restated effective March 1, 1994. See also
Exhibit (10)N hereof. | Incorporated
by reference to Exhibit (10)H(i) of our Form 10-K Annual
Report for the year ended December 31, 2006. See also Exhibit (10)N
hereof. |

SEQ.=1,FOLIO='33',FILE='C:\JMS\105542\09-1718-1\task3384587\1718-1-bi.htm',USER='105542',CD='Feb 25 20:31 2009'

Table of Contents

| | (ii) | Amendment
No. 1 to Ecolab Executive Death Benefits Plan. | Incorporated by
reference to Exhibit (10)H(ii) of our Form 10-K Annual Report
for the year ended December 31, 1998. |
| --- | --- | --- | --- |
| | (iii) | Second Declaration of
Amendment to Ecolab Executive Death Benefits Plan, effective March 1,
1998. | Incorporated by
reference to Exhibit (10)H(iii) of our Form 10-K Annual Report
for the year ended December 31, 1998. |
| | (iv) | Amendment No. 3 to
the Ecolab Executive Death Benefits Plan, effective August 12, 2005. | Incorporated by
reference to Exhibit (10)B of our Form 8-K dated December 13,
2005. |
| I. | | Ecolab Executive
Long-Term Disability Plan, as amended and restated effective January 1,
1994. See also Exhibit (10)N hereof. | Incorporated by
reference to Exhibit (10)I of our Form 10-K Annual Report for the
year ended December 31, 2004. |
| J. | | Ecolab Financial
Counseling Plan (Effective January 1, 2005). | Filed herewith
electronically. |
| K. | | Ecolab Supplemental
Executive Retirement Plan (Amended and Restated effective as of
January 1, 2005). | Filed herewith
electronically. |
| L. | | Ecolab Mirror Savings
Plan (Amended and Restated effective as of January 1, 2005). | Filed herewith
electronically. |
| M. | | Ecolab Mirror Pension
Plan (Amended and Restated effective as of January 1, 2005. | Filed herewith
electronically. |
| N. | | Ecolab Inc.
Administrative Document for Non-Qualified Plans (Amended and Restated
effective as of January 1, 2005). | Filed herewith
electronically. |
| O. | (i) | Ecolab Inc. Management
Performance Incentive Plan, as amended and restated on February 28,
2004. | Incorporated by
reference to Exhibit (10)A of our Form 10-Q for the quarter ended
March 31, 2004. |
| | (ii) | Amendment No. 1
adopted February 26, 2005 to the Ecolab Inc. Management Performance
Incentive Plan. | Incorporated by
reference to Exhibit (10)O(ii) of our Form 10-K Annual Report
for the year ended December 31, 2004. |
| P. | | Ecolab Inc. Change in
Control Severance Compensation Policy, effective as of January 1, 2005,
adopted December 19, 2008. | Filed herewith
electronically. |
| Q. | | Description of Ecolab
Management Incentive Plan. | Filed
herewith electronically. |
| R. | | Stock Purchase
Agreement, dated November 10, 2008, among Henkel AG & Co. KGaA,
Henkel Corporation and Ecolab Inc. | Incorporated by
reference to Exhibit (10.1) of our Form 8-K dated November 10,
2008. |

SEQ.=1,FOLIO='34',FILE='C:\JMS\105542\09-1718-1\task3384587\1718-1-bi.htm',USER='105542',CD='Feb 25 20:31 2009'

Table of Contents

| | (i) | Ecolab Inc. 2002 Stock
Incentive Plan. | Incorporated
by reference to Exhibit (10) of our Form 10-Q for the quarter
ended June 30, 2002. |
| --- | --- | --- | --- |
| | (ii) | Non-statutory Stock
Option Agreement as in effect for grants beginning May 11, 2002 through
August 12, 2003. | Incorporated
by reference to Exhibit (10)A(i) of our Form 10-Q for the
quarter ended June 30, 2004. |
| | (iii) | Non-statutory Stock
Option Agreement as in effect for grants beginning August 13, 2003. | Incorporated
by reference to Exhibit (10)A(ii) of our Form 10-Q for the
quarter ended June 30, 2004. |
| T. | | 2009 Named Executive
Officer Summary of Base Salary, Bonus Award Opportunities, and Executive
Benefits and Perquisites. | Filed
herewith electronically. |
| U. | | Non-Employee Director
Compensation and Benefits Summary. | Filed herewith
electronically. |
| V. | (i) | Ecolab Inc. 2005 Stock
Incentive Plan. | Incorporated by reference
to Exhibit (10)A of our Form 8-K dated May 6, 2005. |
| | (ii) | Amendment No. 1 to
Ecolab Inc. 2005 Stock Incentive Plan, adopted October 31, 2008. | Filed herewith
electronically. |
| | (iii) | Sample form of
Non-Statutory Stock Option Agreement under the Ecolab Inc. 2005 Stock
Incentive Plan. | Incorporated by
reference to Exhibit (10)B of our Form 8-K dated May 6, 2005. |
| | (iv) | Sample form of
Non-Statutory Stock Option Agreement under the Ecolab Inc. 2005 Stock Incentive
Plan in effect for grants after October 31, 2008. | Filed
herewith electronically. |
| | (v) | Sample form of
Restricted Stock Award Agreement under the Ecolab Inc. 2005 Stock Incentive
Plan. | Incorporated by
reference to Exhibit (10)W(iii) of our Form 10-K Annual Report
for the year ended December 31, 2006. |
| W. | | Policy on Reimbursement
of Incentive Payments adopted December 4, 2008 | Filed
herewith electronically. |
| (13) | | Those portions of our
Annual Report to Stockholders for the year ended December 31, 2008 which
are incorporated by reference into Parts I and II hereof. | Filed
herewith electronically. |

SEQ.=1,FOLIO='35',FILE='C:\JMS\105542\09-1718-1\task3384587\1718-1-bi.htm',USER='105542',CD='Feb 25 20:31 2009'

Table of Contents

| (14)A. | Code of Conduct. | Incorporated by
reference to Exhibit (99)A of our Form 10-K Annual Report for the
year ended December 31, 2003. |
| --- | --- | --- |
| (14)B. | Code of Ethics for
Senior Officers and Finance Associates. | Incorporated by
reference to Exhibit (99)B of our Form 10-K Annual Report for the
year ended December 31, 2003. |
| (21) | List of Subsidiaries as
of January 31, 2009. | Filed
herewith electronically. |
| (23) | Consent of Independent
Registered Public Accounting Firm at page 29 hereof is filed as a part
hereof. | See
page 29 hereof. |
| (24) | Powers of Attorney. | Filed
herewith electronically. |
| (31) | Rule 13a-14(a) Certifications. | Filed
herewith electronically. |
| (32) | Section 1350
Certifications. | Filed herewith
electronically. |

SEQ.=1,FOLIO='36',FILE='C:\JMS\105542\09-1718-1\task3384587\1718-1-bi.htm',USER='105542',CD='Feb 25 20:31 2009'

AI assistant

ECOLAB INC. Annual Report 2008

29912_10-k_2009-02-27_c4a794a4-1c5c-4c5a-abb9-93bcaf43f209.zip

AI assistant

ECOLAB INC. — Annual Report 2008

29912_10-k_2009-02-27_c4a794a4-1c5c-4c5a-abb9-93bcaf43f209.zip

More from ECOLAB INC.

ECOLAB INC. Annual Report 2008